Edward Li, PharmD, MPH, BCOP is currently an Associate Professor at the University of New England College of Pharmacy in Portland, ME, where he maintains a practice affiliation with the New England Cancer Specialists in Scarborough, ME. In addition to clinical practice, he works with New Century Health to develop cancer treatment pathways and conducts research using secondary data sources. He earned a PharmD from the Philadelphia College of Pharmacy and a Master of Public Health from the University of New England. His oncology pharmacy residency was at the University of Maryland School of Pharmacy/University of Maryland Medical Center in Baltimore, MD. He has been board certified since 2005.
Ed’s interest in oncology started during pharmacy school, where he was fascinated at the pathophysiology of cancer and the pharmacology of chemotherapy. Lisa Davis had an early influence on his career, when he spent time in her lab studying the systemic exposure of chemotherapy following hepatic chemoembolization. During his oncology residency, Jim Trovato helped further his advancement as an oncology pharmacy practitioner and academic.
Dr. Li has been an active member of HOPA since 2009, and most recently served as Vice-Chair of the Health Policy Committee. In his role on Health Policy Work Groups, he has developed key policy statements for biosimilars and counterfeit drugs on behalf of the organization. Ed has also served on both the BCOP Recertification and Programming Committees. In addition, Ed has been a frequent speaker at the HOPA Annual Conference sharing his expertise on describing and evaluating cancer practice trends, economics, and outcomes.
Past HOPA Involvement
|- Health Policy Committee||Vice Chair||2015–2016|
|- Biosimilars Workgroup||Member||2014–2015|
|- Program Committee||Member||2014–2015|
|- BCOP Recertification Review Panel||Member||2013–2014|
|- Counterfeit Drug Prevention Workgroup||Member||2013–2014|